A detailed history of Washington Trust Advisors, Inc. transactions in Argenx Se stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 7 shares of ARGX stock, worth $4,398. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 2 250.0%
Holding current value
$4,398
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$434.22 - $551.9 $2,171 - $2,759
5 Added 250.0%
7 $3,000
Q2 2024

Jul 25, 2024

SELL
$356.01 - $451.55 $2,492 - $3,160
-7 Reduced 77.78%
2 $0
Q4 2023

Jan 18, 2024

BUY
$338.91 - $506.01 $677 - $1,012
2 Added 28.57%
9 $3,000
Q3 2023

Oct 18, 2023

BUY
$369.35 - $548.43 $2,585 - $3,839
7 New
7 $3,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Washington Trust Advisors, Inc. Portfolio

Follow Washington Trust Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Advisors, Inc. with notifications on news.